Clinical Trials Directory

Trials / Completed

CompletedNCT04243707

Cobalamin Deficiency - Diagnosis and Therapy

Diagnostics and Therapy of a Cobalamin Deficiency

Status
Completed
Phase
Study type
Observational
Enrollment
3,000 (actual)
Sponsor
University Hospital, Basel, Switzerland · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

In a retrospective study with existing values of vitamin B12 and holotranscobalamin 4 strategies are simulated and the results and costs are compared. Generally, cobalamin ist substituted by intramuscular administration. However, oral preparations are also available. Aims of the focus groups are to investigate the awareness of a (potential) deficiency and to identify a therapy for best adherence.

Detailed description

Various diagnostic strategies exist for the identification of a cobalamin deficiency. In a retrospective study with existing serum values of vitamin B12 and holotranscobalamin 4 strategies are simulated and the results and costs are compared. A cobalamin deficiency can have various causes: Dietary habits (vegetarian, vegan), advanced age, pernicious anaemia, gastrectomy, drug interactions (metformin, proton pump blocker). Therapy is often performed by intramuscular administration of cobalamin. However, oral preparations are also available in very different dosages. Investigators want to investigate with focus groups whether different patient groups are aware of a (potential) deficiency, how cobalamin is actually substituted (with registered or otherwise acquired products) and which therapy would lead to best adherence.

Conditions

Timeline

Start date
2017-01-01
Primary completion
2018-12-31
Completion
2019-11-30
First posted
2020-01-28
Last updated
2020-02-12

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT04243707. Inclusion in this directory is not an endorsement.